Acadia Pharmaceuticals reported $6M in Trade Creditors for its second fiscal quarter of 2020.

Trading Economics members can view, download and compare data from nearly 200 countries, including more than 20 million economic indicators, exchange rates, government bond yields, stock indexes and commodity prices.

The Trading Economics Application Programming Interface (API) provides direct access to our data. It allows API clients to download millions of rows of historical data, to query our real-time economic calendar, subscribe to updates and receive quotes for currencies, commodities, stocks and bonds.

Please Paste this Code in your Website
Trade Creditors Change
Acadia Pharmaceuticals ACAD:US $ 6M 0M
Adamas Pharmaceuticals ADMS:US $ 2.47M 1.2M
Alnylam Pharmaceuticals ALNY:US $ 27.87M 1.75M
Biogen BIIB:US $ 398.4M 14.5M
Bristol Myers Squibb BMY:US $ 2852M 217M
Corcept Therapeutics CORT:US $ 6M 2M
Cytokinetics CYTK:US $ 6.74M 3.82M
Eisai 4523:JP Y 61868M 15011M
Eli Lilly And LLY:US $ 1247.2M 39.5M
Intercept Pharmaceuticals ICPT:US $ 28.02M 13.05M
Johnson & Johnson JNJ:US $ 7044M 279M
Pfizer PFE:US $ 3872M 100M
Prothena PRTA:US 2.81M 686K
Ptc Therapeutics PTCT:US $ 15.46M 0.61M
Sarepta Therapeutics SRPT:US $ 91M 65M
Seattle Genetics SGEN:US $ 68.65M 9.42M
Ultragenyx Pharmaceutical RARE:US $ 9.01M 5.39M
Vanda Pharmaceuticals VNDA:US $ 5.42M 0.51M
Vertex Pharmaceuticals VRTX:US $ 101.45M 0.75M
YTE INCY:US $ 90.91M 29.97M
Zogenix ZGNX:US $ 8M 1M